Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-labeled, Randomized Controlled Trial Evaluating for Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine (PCV) in South African Children

NCT02943902 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.

NCT NCT02943902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-labeled, Randomized Controlled Trial Evaluating for Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine (PCV) in South African Children
Lead sponsor
University of Witwatersrand, South Africa
Phase
Phase 3
Overall status
Completed
Start date
January 9, 2017
Completion date
February 26, 2019
Enrollment
600 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

meningitis, pneumonia